Published in Biophys J on September 01, 2002
Sphingomyelin/phosphatidylcholine/cholesterol phase diagram: boundaries and composition of lipid rafts. Biophys J (2003) 4.48
The effect of cholesterol on the lateral diffusion of phospholipids in oriented bilayers. Biophys J (2003) 2.50
Fluorescence probe partitioning between Lo/Ld phases in lipid membranes. Biochim Biophys Acta (2007) 2.25
Intracellular sterol dynamics. Biochim Biophys Acta (2009) 1.79
Sphingomyelin-cholesterol domains in phospholipid membranes: atomistic simulation. Biophys J (2004) 1.55
Miscibility of ternary mixtures of phospholipids and cholesterol in monolayers, and application to bilayer systems. Biophys J (2004) 1.44
Temperature and composition dependence of the interaction of delta-lysin with ternary mixtures of sphingomyelin/cholesterol/POPC. Biophys J (2006) 1.42
Structure and dynamics of sphingomyelin bilayer: insight gained through systematic comparison to phosphatidylcholine. Biophys J (2004) 1.40
Phase diagrams of lipid mixtures relevant to the study of membrane rafts. Biochim Biophys Acta (2008) 1.29
Assessing the nature of lipid raft membranes. PLoS Comput Biol (2007) 1.26
Evidence for the lack of a specific interaction between cholesterol and sphingomyelin. Biophys J (2004) 1.23
Docosahexaenoic acid enhances segregation of lipids between : 2H-NMR study. Biophys J (2008) 1.20
Raftlike mixtures of sphingomyelin and cholesterol investigated by solid-state 2H NMR spectroscopy. J Am Chem Soc (2008) 1.16
Cholesterol in bilayers of sphingomyelin or dihydrosphingomyelin at concentrations found in ocular lens membranes. Biophys J (2003) 1.14
Insight into the putative specific interactions between cholesterol, sphingomyelin, and palmitoyl-oleoyl phosphatidylcholine. Biophys J (2006) 1.11
Yeast lipids can phase-separate into micrometer-scale membrane domains. J Biol Chem (2010) 1.11
Thermodynamic comparison of the interactions of cholesterol with unsaturated phospholipid and sphingomyelins. Biophys J (2006) 1.07
Solvent-free lipid bilayer model using multiscale coarse-graining. J Phys Chem B (2009) 1.05
Self-consistent mean-field model based on molecular dynamics: application to lipid-cholesterol bilayers. J Chem Phys (2005) 1.03
Building up of the liquid-ordered phase formed by sphingomyelin and cholesterol. Biophys J (2005) 0.94
Sterols have higher affinity for sphingomyelin than for phosphatidylcholine bilayers even at equal acyl-chain order. Biophys J (2011) 0.92
An NMR database for simulations of membrane dynamics. Biochim Biophys Acta (2010) 0.91
Solid-state ¹³C NMR reveals annealing of raft-like membranes containing cholesterol by the intrinsically disordered protein α-Synuclein. J Mol Biol (2013) 0.89
Partitioning of pyrene-labeled phospho- and sphingolipids between ordered and disordered bilayer domains. Biophys J (2004) 0.89
Detailed comparison of deuterium quadrupole profiles between sphingomyelin and phosphatidylcholine bilayers. Biophys J (2014) 0.86
Use of fluorescence to determine the effects of cholesterol on lipid behavior in sphingomyelin liposomes and erythrocyte membranes. J Lipid Res (2008) 0.86
Characterization of the water defect at the HIV-1 gp41 membrane spanning domain in bilayers with and without cholesterol using molecular simulations. Biochim Biophys Acta (2014) 0.80
Modification of Lipid Bilayer Structure by Diacylglycerol: A Comparative Study of Diacylglycerol and Cholesterol. J Chem Theory Comput (2012) 0.80
Unique backbone-water interaction detected in sphingomyelin bilayers with 1H/31P and 1H/13C HETCOR MAS NMR spectroscopy. Biophys J (2008) 0.79
Area per lipid and cholesterol interactions in membranes from separated local-field (13)C NMR spectroscopy. Biophys J (2014) 0.79
The Influence of Hydrogen Bonding on Sphingomyelin/Colipid Interactions in Bilayer Membranes. Biophys J (2016) 0.76
Phase equilibria of cholesterol/dipalmitoylphosphatidylcholine mixtures: 2H nuclear magnetic resonance and differential scanning calorimetry. Biochemistry (1990) 8.63
Elastic deformation and failure of lipid bilayer membranes containing cholesterol. Biophys J (1990) 5.66
How cells handle cholesterol. Science (2000) 5.56
Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol (2000) 3.27
Maximum solubility of cholesterol in phosphatidylcholine and phosphatidylethanolamine bilayers. Biochim Biophys Acta (1999) 3.13
Cholesterol-induced fluid-phase immiscibility in membranes. Proc Natl Acad Sci U S A (1991) 2.88
Interaction of cholesterol with various glycerophospholipids and sphingomyelin. Biochemistry (1990) 2.77
Spectroscopic studies of specifically deuterium labeled membrane systems. Nuclear magnetic resonance investigation of the effects of cholesterol in model systems. Biochemistry (1978) 2.71
Effect of a single cis double bond on the structures of a phospholipid bilayer. Biochemistry (1977) 2.42
The relationship between membrane fluidity and permeabilities to water, solutes, ammonia, and protons. J Gen Physiol (1995) 2.17
Structure and cohesive properties of sphingomyelin/cholesterol bilayers. Biochemistry (1992) 1.95
Influence of molecular packing and phospholipid type on rates of cholesterol exchange. Biochemistry (1988) 1.75
Interaction of cholesterol with sphingomyelin in monolayers and vesicles. Biochemistry (1994) 1.66
Sphingomyelin--lecithin bilayers and their interaction with cholesterol. Biochemistry (1979) 1.66
Biophysics of lipidic associations. II. The ternary systems: cholesterol-lecithin-water. Biochim Biophys Acta (1967) 1.53
Cyclodextrin-mediated removal of sterols from monolayers: effects of sterol structure and phospholipids on desorption rate. Biochemistry (1996) 1.48
Head-group conformation in phospholipids: a phosphorus-31 nuclear magnetic resonance study of oriented monodomain dipalmitoylphosphatidylcholine bilayers. Biochemistry (1978) 1.36
Cholesterol orientation and dynamics in dimyristoylphosphatidylcholine bilayers: a solid state deuterium NMR analysis. Biophys J (1999) 1.30
Role of BBM lipid composition and fluidity in impaired renal Pi transport in aged rat. Am J Physiol (1989) 1.28
Effects of cholesterol and cholesterol derivatives on hydrocarbon chain mobility in lipids. Biochem Biophys Res Commun (1971) 1.21
Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis. J Lipid Res (1998) 1.13
The affinity of cholesterol for phosphatidylcholine and sphingomyelin. Biochim Biophys Acta (1979) 1.13
Phase behavior and structure of aqueous dispersions of sphingomyelin. J Lipid Res (1974) 1.10
A nuclear magnetic resonance study of sphingomyelin in bilayer systems. Biochemistry (1977) 1.06
13C MAS NMR studies of crystalline cholesterol and lipid mixtures modeling atherosclerotic plaques. Biophys J (1996) 1.03
Sphingolipid signalling domains floating on rafts or buried in caves? Cell Signal (2000) 1.02
A (2)H NMR study of macroscopically aligned bilayer membranes containing interfacial hydroxyl residues. Biophys J (2000) 1.02
A multinuclear solid-state NMR study of phospholipid-cholesterol interactions. Dipalmitoylphosphatidylcholine-cholesterol binary system. Biochemistry (1995) 1.00
Interactions between cholesterol and lipids in bilayer membranes. Role of lipid headgroup and hydrocarbon chain-backbone linkage. Biochim Biophys Acta (2000) 1.00
Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesions. Am J Pathol (1990) 0.98
Enzyme-catalyzed oxidation of cholesterol in mixed phospholipid monolayers reveals the stoichiometry at which free cholesterol clusters disappear. Biochemistry (1992) 0.96
The rate of sphingomyelin synthesis de novo is influenced by the level of cholesterol in cultured human skin fibroblasts. Biochem J (1998) 0.91
Interaction of sphingomyelins and phosphatidylcholines with fluorescent dehydroergosterol. Biochemistry (1989) 0.87
Lipid changes with aging in cardiac mitochondrial membranes. Mech Ageing Dev (1984) 0.87
The bilayer stabilizing role of sphingomyelin in the presence of cholesterol: a 31P NMR study. Biochim Biophys Acta (1980) 0.83
The influence of cholesterol on head group mobility in phospholipid membranes. Biochim Biophys Acta (1979) 0.83
Difference in orientational order in phospholipid and sphingomyelin bilayers. FEBS Lett (1979) 0.79
Effect of long-term feeding with acetyl-L-carnitine on the age-related changes in rat brain lipid composition: a study by 31P NMR spectroscopy. Neurochem Res (2000) 0.79
Age related changes in platelet lipid composition. Thromb Res (1986) 0.78
Interaction of sex hormones and cholesterol with monolayers of dipalmitoylphosphatidylcholine in different phase state. J Steroid Biochem Mol Biol (1998) 0.78
Refeeding varying fatty acid and cholesterol diets alters phospholipids in rat intestinal brush border membrane. Lipids (1997) 0.77
Telaprevir for previously treated chronic HCV infection. N Engl J Med (2010) 8.33
Response-guided telaprevir combination treatment for hepatitis C virus infection. N Engl J Med (2011) 6.31
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology (2010) 6.14
Liver cirrhosis. Lancet (2008) 6.11
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med (2007) 5.13
Exceeding the limits of liver histology markers. J Hepatol (2008) 5.06
Chimeric 16S rDNA sequences of diverse origin are accumulating in the public databases. Int J Syst Evol Microbiol (2003) 4.03
Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab (2008) 3.78
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial. Lancet Infect Dis (2013) 3.30
Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med (2007) 3.18
Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology (2006) 2.96
Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol (2005) 2.64
Bilateral olfactory sensory input enhances chemotaxis behavior. Nat Neurosci (2007) 2.53
Functional role of the "ionic lock"--an interhelical hydrogen-bond network in family A heptahelical receptors. J Mol Biol (2008) 2.47
The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron (2003) 2.43
Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS (2005) 2.34
Curvature and hydrophobic forces drive oligomerization and modulate activity of rhodopsin in membranes. Biophys J (2006) 2.23
Diagnosis and quantitation of fibrosis. Gastroenterology (2008) 2.20
Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. J Hepatol (2011) 2.20
Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J (2010) 2.12
Duration of peginterferon therapy in acute hepatitis C: a randomized trial. Hepatology (2006) 2.11
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. Gastroenterology (2010) 2.06
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS (2007) 1.92
G protein-coupled receptors self-assemble in dynamics simulations of model bilayers. J Am Chem Soc (2007) 1.90
Biophysical properties of human antibody variable domains. J Mol Biol (2003) 1.80
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction. Gastroenterology (2010) 1.74
Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus. Hepatology (2007) 1.73
Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study. J Biol Chem (2004) 1.73
The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol (2007) 1.73
Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. PLoS Biol (2007) 1.72
Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci U S A (2009) 1.64
Rapid incorporation of functional rhodopsin into nanoscale apolipoprotein bound bilayer (NABB) particles. J Mol Biol (2008) 1.64
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial. Gastroenterology (2013) 1.63
Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol (2011) 1.62
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients. J Hepatol (2011) 1.59
Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology (2011) 1.53
FTIR analysis of GPCR activation using azido probes. Nat Chem Biol (2009) 1.52
Early-life sodium exposure unmasks susceptibility to stroke in hyperlipidemic, hypertensive heterozygous Tg25 rats transgenic for human cholesteryl ester transfer protein. Circulation (2009) 1.51
Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res (2008) 1.48
Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1. J Hepatol (2011) 1.47
Site-specific incorporation of keto amino acids into functional G protein-coupled receptors using unnatural amino acid mutagenesis. J Biol Chem (2007) 1.45
Differential effects of Parkinson's disease-associated mutations on stability and folding of DJ-1. J Biol Chem (2003) 1.45
Membrane model for the G-protein-coupled receptor rhodopsin: hydrophobic interface and dynamical structure. Biophys J (2004) 1.41
Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology (2007) 1.40
The N-terminus of the intrinsically disordered protein α-synuclein triggers membrane binding and helix folding. Biophys J (2010) 1.39
Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C. Hepatology (2007) 1.38
Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C. J Clin Pharmacol (2009) 1.37
Protein contact prediction using patterns of correlation. Proteins (2004) 1.34
Y-chromosomal variation in sub-Saharan Africa: insights into the history of Niger-Congo groups. Mol Biol Evol (2010) 1.32
Systematic characterization of the zinc-finger-containing proteins in the mouse transcriptome. Genome Res (2003) 1.31
How fatty acids of different chain length enter and leave cells by free diffusion. Prostaglandins Leukot Essent Fatty Acids (2006) 1.31
Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology (2006) 1.30
Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy. Hepatology (2004) 1.30
Rheology of gastric mucin exhibits a pH-dependent sol-gel transition. Biomacromolecules (2007) 1.29
Numbat: an interactive software tool for fitting Deltachi-tensors to molecular coordinates using pseudocontact shifts. J Biomol NMR (2008) 1.28
Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology (2003) 1.27
Opsin is a phospholipid flippase. Curr Biol (2011) 1.27
Wurst: a protein threading server with a structural scoring function, sequence profiles and optimized substitution matrices. Nucleic Acids Res (2004) 1.23
Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology (2007) 1.23
Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. J Mol Biol (2006) 1.22
Prediction of cis/trans isomerization in proteins using PSI-BLAST profiles and secondary structure information. BMC Bioinformatics (2006) 1.20
Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology (2010) 1.20
Structural basis for recruitment of tandem hotdog domains in acyl-CoA thioesterase 7 and its role in inflammation. Proc Natl Acad Sci U S A (2007) 1.20
Structural determinants of the supramolecular organization of G protein-coupled receptors in bilayers. J Am Chem Soc (2012) 1.20
Binding of alpha-synuclein affects the lipid packing in bilayers of small vesicles. J Biol Chem (2006) 1.18
Structure of docosahexaenoic acid-containing phospholipid bilayers as studied by (2)H NMR and molecular dynamics simulations. J Am Chem Soc (2002) 1.17
Raftlike mixtures of sphingomyelin and cholesterol investigated by solid-state 2H NMR spectroscopy. J Am Chem Soc (2008) 1.16
Predicting disulfide connectivity from protein sequence using multiple sequence feature vectors and secondary structure. Bioinformatics (2007) 1.14
Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis? Clin Chem (2004) 1.13
Ultrasound-based hepatic elastography: origins, limitations, and applications. J Clin Gastroenterol (2010) 1.12
Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Mol Cell Endocrinol (2008) 1.12
An inflammatory role for the mammalian carboxypeptidase inhibitor latexin: relationship to cystatins and the tumor suppressor TIG1. Structure (2005) 1.11
Phosphoregulators: protein kinases and protein phosphatases of mouse. Genome Res (2003) 1.11
Atomic force microscopy reveals aggregation of gastric mucin at low pH. Biomacromolecules (2005) 1.11
Identification of atherosclerotic lipid deposits by diffusion-weighted imaging. Arterioscler Thromb Vasc Biol (2007) 1.10
Mapping the ligand-binding site on a G protein-coupled receptor (GPCR) using genetically encoded photocrosslinkers. Biochemistry (2011) 1.09
Rhodopsin forms a dimer with cytoplasmic helix 8 contacts in native membranes. Biochemistry (2012) 1.09
Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. J Hepatol (2011) 1.09
EUS-guided liver biopsy: a procedure looking for an indication. Gastrointest Endosc (2009) 1.08
Structure and lipid interaction of N-palmitoylsphingomyelin in bilayer membranes as revealed by 2H-NMR spectroscopy. Biophys J (2005) 1.07
Fast structure-based assignment of 15N HSQC spectra of selectively 15N-labeled paramagnetic proteins. J Am Chem Soc (2004) 1.07
Predikin and PredikinDB: a computational framework for the prediction of protein kinase peptide specificity and an associated database of phosphorylation sites. BMC Bioinformatics (2008) 1.07
A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res (2009) 1.06
Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology (2012) 1.06
Targeted binding of PLA microparticles with lipid-PEG-tethered ligands. Biomaterials (2007) 1.05
A dipicolinic acid tag for rigid lanthanide tagging of proteins and paramagnetic NMR spectroscopy. J Am Chem Soc (2008) 1.05
In vivo detection of vulnerable atherosclerotic plaque by MRI in a rabbit model. Circ Cardiovasc Imaging (2010) 1.04
Fatty acid flip-flop in a model membrane is faster than desorption into the aqueous phase. Biochemistry (2008) 1.04
Genetically encoded photo-cross-linkers map the binding site of an allosteric drug on a G protein-coupled receptor. ACS Chem Biol (2012) 1.04
Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial. Hepatology (2013) 1.03
Crystallography and protein-protein interactions: biological interfaces and crystal contacts. Biochem Soc Trans (2008) 1.03
Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice. Atherosclerosis (2010) 1.02
Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen. J Immunol (2012) 1.02
Gadolinium tagging for high-precision measurements of 6 nm distances in protein assemblies by EPR. J Am Chem Soc (2011) 1.02
Management of hepatitis C virus in special populations: patient and treatment considerations. Clin Gastroenterol Hepatol (2005) 1.01
A direct proofreader-clamp interaction stabilizes the Pol III replicase in the polymerization mode. EMBO J (2013) 1.01
Viscoelastic properties and dynamics of porcine gastric mucin. Biomacromolecules (2005) 1.01
Protein structure determination from pseudocontact shifts using ROSETTA. J Mol Biol (2012) 1.01
Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts. J Am Chem Soc (2011) 1.01
The relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome. Obesity (Silver Spring) (2009) 1.00